Clinical Trial Update: Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the pharmacological effect of lysozyme for chronic obstructive pulmonary disease and asthma has completed. The study was sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Lysozyme (lysozyme)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease, Asthma | Phase 4 | Status: COMPLETED